等待開盤 09-22 09:30:00 美东时间
0.000
0.00%
今日重点评级关注:Needham:上调爱美医疗评级至"买入",目标价14美元;高盛:维持Roivant Sciences"买入"评级,目标价从20美元升至24美元
09-19 09:18
During the last three months, 12 analysts shared their evaluations of argenx (N...
09-19 05:00
Expansion of partnership broadens argenx' manufacturing capabilities in the U.S., supporting its strategy of local-for-local supply of medicinesHOLLY SPRINGS, N.C.--(BUSINESS WIRE)--FUJIFILM Biotechnologies, a
09-18 21:15
今日重点评级关注:Benchmark:维持Unicycive Therapeutics"投机性买入"评级,目标价从3美元升至21美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从17美元升至25美元
09-16 09:48
Truist Securities analyst Joon Lee maintains argenx (NASDAQ:ARGX) with a Buy and raises the price target from $700 to $918.
09-15 21:08
argenx (NASDAQ:ARGX) has outperformed the market over the past 5 years by 12.84...
09-11 06:00
argenx's (NYSE:ARGX) short percent of float has fallen 4.11% since its last rep...
09-09 03:00
B of A Securities analyst Tazeen Ahmad maintains argenx (NASDAQ:ARGX) with a Buy and raises the price target from $880 to $887.
09-02 23:38
argenx, a global immunology company focused on severe autoimmune diseases, announced that its management team will participate in two investor conferences in September. On September 4, 2025, there will be a fireside chat at the Wells Fargo Healthcare Conference in Boston, MA. Another fireside chat will occur on September 8, 2025, at the Morgan Stanley Global Healthcare Conference in New York, NY. Webcasts of these presentations will be available ...
08-28 05:00